Genetic Analysis aktie (GEAN) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Investeringsmöjlighet: Bli delägare i global ledare inom AI-baserad videoanalys på säkerhetsmarknaden (annons)

Pressmeddelanden från Genetic Analysis

 Bevaka pressreleaser
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

Genetic Analysis AS: Interim report January – September 2024

OSLO, NORWAY – 15 November 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for t...

Cision • 15 Nov 08:00

Genetic Analysis AS: Publication of Half-year report 2024

OSLO, NORWAY – 30 August 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for H1,...

Cision • 30 Aug 08:00

Genetic Analysis directed issue to major shareholders has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis AS' (“GA” or the “Company”) directed issue to current major shareholders and certain members of the board of directors and ...

Cision • 14 Aug 08:00

Genetic Analysis AS: Minutes from the Extraordinary General Meeting 17 July 2024

Oslo, Norway, July 17, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) held an Extraordinary General Meeting today, July 17[th], at...

Cision • 17 Jul 17:30

Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises

OSLO, NORWAY - July 15, 2024: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that the direct issue which...

Cision • 15 Jul 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 04 July 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 04 Jul 08:00

Genetic Analysis AS: Notice of Extraordinary General Meeting 2024

Oslo, Norway, July 3, 2024 - Notice is hereby served that an extraordinary general meeting of Genetic Analysis AS (the "Company") will be he...

Cision • 03 Jul 15:00

Genetic Analysis: Flagging notification

OSLO, NORWAY - July 1, 2024: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that an existing shareholder...

Cision • 01 Jul 10:43

Genetic Analysis announces placement of a directed share issue of approximately NOK 4.97 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 01 Jul 09:00

Genetic Analysis: Awarded important EU patent covering a companion diagnostic method for optimising IBS interventions

OSLO, NORWAY – 13 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today the grant of an important pat...

Cision • 13 Jun 08:00

Genetic Analysis AS: CFO resigns to pursue other opportunities

OSLO, NORWAY – 06 June 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that Eilert Aamodt has decided to r...

Cision • 06 Jun 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 3 June 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board of directors has bought GEAN-sh...

Cision • 03 Jun 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 31 May 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the board of directors has bought GEAN-sh...

Cision • 31 May 08:00

Genetic Analysis AS: Publication of Q1 report January – March 2024

OSLO, NORWAY – May 29, 2024: Today, Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby publishes the interim report fo...

Cision • 29 May 08:00

Minutes from the Annual General Meeting 2024 in Genetic Analysis AS

Oslo, Norway, May 15, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) held its Annual General Meeting yesterday, May 14[th], at 15:...

Cision • 15 May 08:00

Genetic Analysis AS: Notice of Annual General Meeting 2024

Oslo, Norway, April 24, 2024 - Notice is hereby served that the annual general meeting of Genetic Analysis AS (the "Company") will be held o...

Cision • 24 Apr 18:30

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 19 April 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 19 Apr 08:00

Genetic Analysis AS: Publication of Annual Report 2023

Oslo, Norway, April 18, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the Annual Report for the financial year o...

Cision • 18 Apr 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 14 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 14 Mar 08:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insider

OSLO, NORWAY – 11 March 2024: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 11 Mar 08:00

Year-end report January – December 2023

Oslo, Norway, February 29, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the year-end report for the period 1 Ja...

Cision • 29 Feb 08:00

Bokslutskommuniké januari – december 2023

Oslo, Norge, 29 februari 2024 - Genetic Analysis AS ("Bolaget", Ticker: GEAN) offentliggör härmed bokslutskommuniké avseende 2023.

Cision • 29 Feb 08:00

Genetic Analysis AS: Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit

Oslo, Norway, November 26, 2024 - Genetic Analysis AS (the "Company", Ticker: GEAN) is proud to announce that its GA-map® Sample Collection ...

Cision • 26 Feb 08:00

Genetic Analysis AS: Genetic Analysis AS erhåller CE-IVDR-märkning för sitt GA-map® provtagningskit

Oslo, Norge, 26 februari, 2024 - Genetic Analysis AS ("Bolaget", Ticker: GEAN) är stolta över att meddela att GA-map® Sample Collection Kit ...

Cision • 26 Feb 08:00

Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis AS' (“GA” or the “Company”) subsequent offering to existing shareholders, for which the subscription period ended on Decemb...

Cision • 10 Jan 14:01

Genetic Analysis announces final outcome of the subsequent offering to existing shareholders

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 27 Dec 2023 13:00

Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 22 Dec 2023 14:45

Genetic Analysis ingår partnerskap för att ta steget in på konsumentmarknaden med GA-map®

OSLO, NORGE – 21 december 2023: Mikrobiom DX-bolaget Genetic Analysis AS ("GA" eller "Bolaget") tillkännager idag ett samarbete med Comono A...

Cision • 21 Dec 2023 08:00

Genetic Analysis partners up to enter the consumer market with GA-map®

OSLO, NORWAY - December 21, 2023: Today, Microbiome DX company Genetic Analysis AS ("GA" or the "Company") announces a collaboration with Co...

Cision • 21 Dec 2023 08:00

BioStock: Genetic Analysis mot fortsatt expansion

Norge-baserade Genetic Analysis har utvecklat världens enda, enligt bolaget, CE-IVD-märkta rutindiagnostiska verktyg för analys av tarmmikro...

Cision • 15 Dec 2023 08:33

Genetic Analysis sammanfattar årets produktutvecklingsaktiviteter och blickar framåt mot 2024

OSLO, NORGE - 13 december 2023: Idag publicerar mikrobiom DX-bolaget Genetic Analysis AS ("GA" eller "Bolaget") en sammanfattning av innevar...

Cision • 13 Dec 2023 08:00

Genetic Analysis summarizes this year's product development activities and looks ahead to 2024

OSLO, NORWAY - December 13, 2023: Today, the Microbiome DX company Genetic Analysis AS ("GA" or the "Company") publishes a summary of the cu...

Cision • 13 Dec 2023 08:00

BioStock: Genetic Analysis vd: ”vi är unikt positionerade för tillväxt”

Norska Genetic Analysis har utvecklat, enligt bolaget, världens enda CE-IVD-märkta rutindiagnostiska verktyg för analys av tarmens mikrobiot...

Cision • 12 Dec 2023 08:53

Today, the subscription period in Genetic Analysis subsequent offering begins

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 11 Dec 2023 08:00

Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 08 Dec 2023 15:40

Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 08 Dec 2023 13:35

Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 30 Nov 2023 18:00

Genetic Analysis AS offentliggör utfall i optionsinlösen

OSLO, NORGE - 23 november, 2023 – Den 22 november 2023 avslutades nyttjandeperioden för de teckningsoptioner av serie TO 2 som emitterades i...

Cision • 23 Nov 2023 18:00

Genetic Analysis AS: Mandatory notification of trade

OSLO, NORWAY – 20 November 2023: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and Management have been al...

Cision • 20 Nov 2023 14:35

Genetic Analysis AS: Minutes from the Extraordinary General Meeting

Oslo, Norway, November 20, 2023 - Genetic Analysis AS (the "Company", Ticker: GEAN) held an Extraordinary General Meeting today, November 20...

Cision • 20 Nov 2023 14:30

Presentation av GA-map® från Genetic Analysis väcker stort intresse på xMAP® Connect EMEA i Amsterdam

OSLO, NORGE – 16 november 2023: Mikrobiom DX-företaget Genetic Analysis AS (“GA” eller “Bolaget”) meddelar idag att Bolaget nyligen presente...

Cision • 16 Nov 2023 15:08

Presentation of GA-map® by Genetic Analysis sparks great interest at xMAP® Connect EMEA in Amsterdam

OSLO, NORWAY, November 16, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the Company recently...

Cision • 16 Nov 2023 15:08

Genetic Analysis – Capital raise give boost – Mangold Insight Analysis

Genetic Analysis, a diagnostic company within Life Science, is growing rapidly.

Cision • 16 Nov 2023 08:00

Notice of Extraordinary General Meeting 2023

Notice is hereby served that an extraordinary general meeting in Genetic Analysis AS (the "Company") will be held on Monday 20 November 2023...

Cision • 06 Nov 2023 13:13

Information avseende nyttjandeperiod av teckningsoptioner av serie TO 2 i Genetic Analysis AS

OSLO, NORGE - 3 november, 2023 – Den 8 november 2023 inleds nyttjandeperioden för de teckningsoptioner av serie TO 2 som emitterades i samba...

Cision • 03 Nov 2023 18:00

Correction: Updated intended record date for the intended Subsequent Offering announced in press release, November 2, 2023

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 03 Nov 2023 16:16

Subscriptions received in separate tranche of previously announced directed share issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 03 Nov 2023 08:56

Styrelseledamot avgår på egen begäran

OSLO, NORGE – 2 november, 2023: Mikrobiom DX-bolaget Genetic Analysis AS ("GA") meddelar idag att styrelseledamoten Staffan Strömberg har av...

Cision • 02 Nov 2023 20:31

Board member resigns at his request

OSLO, NORWAY – November 2, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the board member Sta...

Cision • 02 Nov 2023 20:31

Delårsrapport januari–september 2023

OSLO, NORGE, 2 november 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) offentliggör härmed delårsrapport avseende det tredje kvartalet oc...

Cision • 02 Nov 2023 20:10

Interim report January – September 2023

OSLO, NORWAY, November 2, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the third quarter and t...

Cision • 02 Nov 2023 20:10

Genetic Analysis announces placement of directed share issue of appr. NOK 10 mill, intention to conduct subsequent offering to shareholders, non-binding LoI for further investment, updated milestones

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NE...

Cision • 02 Nov 2023 20:00

Genetic Analysis: Launch of GA-map® Discovery – A microbiome profiling offering for Research Customers

OSLO, NORWAY – 24 October 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces today that the Company launches ...

Cision • 24 Oct 2023 08:00

Genetic Analysis: Lansering av GA-map® Discovery – Ett mikrobiomprofileringserbjudande för forskningskunder

OSLO, NORGE – 24 oktober 2023: Mikrobiom DX-företaget Genetic Analysis AS (“GA” eller “Bolaget”) meddelar idag att Bolaget lanserar GA-map® ...

Cision • 24 Oct 2023 08:00

Genetic Analysis: Initierat utvecklingsprojekt för nytt companion diagnostic-test

OSLO, NORGE, 12 oktober 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) meddelar att Bolaget framgångsrikt har slutfört ett pilotprojekt o...

Cision • 12 Oct 2023 08:00

Genetic Analysis: Development project initiated for a new companion diagnostic test

OSLO, NORWAY – 12 October 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has successfull...

Cision • 12 Oct 2023 08:00

Genetic Analysis - Growth and cost reduction – Mangold Insight Analys

Genetic Analysis, with its GA-map technology, increased sales by 22 percent in the second quarter to 3.

Cision • 06 Sep 2023 08:30

Genetic Analysis - Tillväxt och sänkta kostnader – Mangold Insight Analys

Genetic Analysis med dess GA-map teknologi ökade försäljningen med 22 procent under det andra kvartalet till 3,7 miljoner norska kronor* jäm...

Cision • 06 Sep 2023 08:30

Half-year report January–June 2023

OSLO, NORWAY, August 30, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the half-year report for the second quarter and...

Cision • 30 Aug 2023 08:00

Halvårsrapport januari–juni 2023

OSLO, NORGE, 30 augusti 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) offentliggör härmed halvårsrapport avseende det andra kvartalet oc...

Cision • 30 Aug 2023 08:00

Genetic Analysis AS stärker sin marknadsnärvaro i USA med mikrobiomtestet GA-map[®]

OSLO, NORGE – 25 augusti 2023: Mikrobiomdiagnostikspecialisten Genetic Analysis AS ("GA") har genom sin distributör Eagle Biosciences Inc in...

Cision • 25 Aug 2023 08:00

Genetic Analysis AS ramps up its market presence for the GA-map[®] microbiome testing in the US

OSLO, NORWAY – August 25, 2023: Microbiome diagnostics specialist, Genetic Analysis AS (“GA”) has through its distributor Eagle Biosciences ...

Cision • 25 Aug 2023 08:00

Ny publikation visar fördelarna med testplattformen GA-map® vid diabetes typ 2

OSLO, NORGE - 23 augusti 2023: Mikrobiom DX-bolaget Genetic Analysis AS ("GA" eller "Bolaget") meddelar att en vetenskaplig artikel nyligen ...

Cision • 23 Aug 2023 08:00

New publication shows the benefits of the GA-map® testing platform in Diabetes Type 2

OSLO, NORWAY – 23 August 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that a scientific article has rec...

Cision • 23 Aug 2023 08:00

Genetic Analysis erhåller patentgodkännande i Sydafrika

OSLO, NORGE – 29 Juni 2023: Mikrobiom DX-bolaget Genetic Analysis AS ("GA" eller "Bolaget") meddelar att Bolaget har erhållit ett patentgodk...

Cision • 29 Jun 2023 08:00

Genetic Analysis receives patent approval in South Africa

OSLO, NORWAY – June 29, 2023: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has been awarded ...

Cision • 29 Jun 2023 08:00

Genetic Analysis AS ingår avtal med ELTA90 Group för att distribuera och lansera GA-map[®]-teknologin i Balkanregionen

Oslo, Norge, 8 Juni, 2023 – Genetic Analysis (”GA”), specialist på molekylär diagnostik, har ingått ett distributionsavtal med ELTA90 Group ...

Cision • 08 Jun 2023 08:00

Genetic Analysis AS enters an agreement with ELTA90 Group to distribute and launch GA-map[®] technology in the Balkan region

OSLO, NORWAY – 8 June 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) has entered a distribution agreement with ELTA90 Gr...

Cision • 08 Jun 2023 08:00

Genetic Analysis - Diagnostik på tillväxt - Mangold Insight Analys

Genetic Analysis, ett medicintekniskt diagnostikbolag inriktat mot mikrobiom, ökade sina totala intäkter till 6,4 miljoner norska kronor* un...

Cision • 02 Jun 2023 13:00

Genetic Analysis - Diagnostic company on growth - Mangold Insight Analys

Genetic Analysis, a microbiome diagnostic company, increased its total revenue to NOK 6,4 million in the first quarter.

Cision • 02 Jun 2023 13:00

Genetic Analysis AS: Mandatory notification of trade – Primary Insiders

OSLO, NORWAY – 26 May 2023: Genetic Analysis AS (“GA” or “the Company”) announces that a member of the management has bought GEAN-shares.

Cision • 26 May 2023 08:00

Interim report January–March 2023

OSLO, NORWAY, May 25, 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the first quarter of 2023.

Cision • 25 May 2023 08:00

Delårsrapport januari–mars 2023

OSLO, NORGE, 25 maj 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) offentliggör härmed delårsrapport avseende det första kvartalet 2023.

Cision • 25 May 2023 08:00

Minutes from the Annual General Meeting 2023 in Genetic Analysis AS

Oslo, Norway, May 11, 2023 - Genetic Analysis AS (the "Company", Ticker: GEAN) held its Annual General Meeting today, May 11[th], at 15:00 h...

Cision • 11 May 2023 16:49

Notice of Annual General Meeting 2023

Notice is hereby served that the annual general meeting of Genetic Analysis AS (the "Company") will be held on Thursday 11 May 2023 at 15:00...

Cision • 28 Apr 2023 08:00

Publication of Genetic Analysis’ 2022 Annual Report

(Oslo, April 20, 2023) Genetic Analysis AS (“GA” or “the Company”) hereby publishes the Annual Report for the financial year of 2022.

Cision • 20 Apr 2023 08:00

Genetic Analysis offentliggör årsredovisning för helåret 2022

(Oslo, 20 april 2023) Genetic Analysis AS (“GA” eller “Bolaget”) offentliggör härmed årsredovisning avseende helåret 2022.

Cision • 20 Apr 2023 08:00

Genetic Analysis presenterar på Mangold Insights Investerardag

OSLO, NORGE, 17 mars 2023 – Genetic Analysis ("GA") kommer att delta vid Mangold Insights Investerardag nästa onsdag, den 22 mars 2023.

Cision • 17 Mar 2023 11:45

Genetic Analysis presents at Mangold Insight’s Investor Day

OSLO, NORWAY, March 17, 2023 – Genetic Analysis (“GA”) will attend Mangold Insight’s Investor Day next Wednesday, 22 March 2023.

Cision • 17 Mar 2023 11:45

Genetic Analysis - Tar nästa steg - Mangold Insight Analys

Genetic Analysis, ett medicintekniskt diagnostikbolag inriktat mot mikrobiota, har under 2022 etablerat en plattform för GA-map med återkomm...

Cision • 24 Feb 2023 13:30

Bokslutskommuniké januari – december 2022

OSLO, NORGE, 17 februari 2023 – Genetic Analysis AS (“GA” eller “Bolaget”) offentliggör härmed bokslutskommuniké avseende 2022.

Cision • 17 Feb 2023 08:00

Year-end report January – December 2022

OSLO, NORWAY, 17 February 2023 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the year-end report for the period 1 January –...

Cision • 17 Feb 2023 08:00

Genetic Analysis strengthens and future-proofs the organization

OSLO, NORWAY, January 31, 2023 – Molecular diagnostics specialist, Genetic Analysis AS (“GA”) is happy to announce that GA is strengthening ...

Cision • 31 Jan 2023 08:00

Genetic Analysis stärker och framtidsäkrar organisationen

Oslo, Norge, 31 Januari, 2023 – Genetic Analysis (”GA”), specialist på molekylär diagnostik, är glada att kunna meddela att GA stärker och f...

Cision • 31 Jan 2023 08:00

Genetic Analysis CTO finalist i Lyfebulb 2022 Innovation Challenge för att möta de ouppfyllda behoven inom IBD

Oslo, Norge, 27 Januari, 2023 – Genetic Analysis (”GA”), specialist på molekylär diagnostik, är glada att kunna meddela att GA:s teknikchef ...

Cision • 27 Jan 2023 08:00

Genetic Analysis’ CTO finalist in the Lyfebulb and Bristol Myers Squibb Innovation Challenge addressing unmet needs in IBD

OSLO, NORWAY, January 27, 2023 – Molecular diagnostics specialist, Genetic Analysis AS (“GA”) is happy to announce that GA’s Chief Technolog...

Cision • 27 Jan 2023 08:00

Genetic Analysis AS erhåller thailändsk FDA-licens för GA-map[®] Dysbiosis Test i Thailand

OSLO, NORGE – 19 januari 2023: Genetic Analysis AS ("GA"), specialist på molekylär diagnostik, kan med glädje meddela att thailändska Food a...

Cision • 19 Jan 2023 08:00

Genetic Analysis AS achieves Thai FDA License for GA-map[®] Dysbiosis Test in Thailand

OSLO, NORWAY – 19 January 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) are happy to announce that Thailand Food and Dr...

Cision • 19 Jan 2023 08:00

Genetic Analysis AS ingår avtal med Microbiome Research Pvt. Ltd. för att lansera GA-map[®]-tekniken i Indien

OSLO, NORGE – 16 januari 2022: Genetic Analysis AS ("GA"), specialist på molekylär diagnostik, har ingått ett avtal om tekniköverföring med ...

Cision • 16 Jan 2023 08:00

Genetic Analysis AS enters an agreement with Microbiome Research Pvt. Ltd. to launch GA-map[®] technology in India

OSLO, NORWAY – 16 January 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) has entered a Tech Transfer Agreement with Micr...

Cision • 16 Jan 2023 08:00

Genetic Analysis AS enters an agreement with Hausen Bernstein Co. Ltd. to launch GA-map[®] technology in Thailand

OSLO, NORWAY – November 30, 2022: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) has entered a tech transfer and distribution ...

Cision • 30 Nov 2022 08:00

Genetic Analysis ingår avtal med Hausen Bernstein om lansering av GA-map[®] i Thailand

OSLO, NORGE - 30 november 2022: Genetic Analysis AS ("GA"), specialist på molekylär diagnostik, har ingått ett avtal om tekniköverföring och...

Cision • 30 Nov 2022 08:00

Genetic Analysis - Rustar för ökad efterfrågan - Mangold Insight Analys

Genetic Analysis, ett diagnostikbolag inriktat mot mikrobiota, vars försäljning börjat öka men från låga nivåer.

Cision • 23 Nov 2022 08:00

Genetic Analysis AS offentliggör utfall i optionsinlösen

Oslo, Norge, 21 november 2022 – Den 16 november 2022 avslutades nyttjandeperioden för Genetic Analysis AS:s (“GA” eller “Bolaget”) tecknings...

Cision • 21 Nov 2022 08:00

Genetic Analysis AS announces the outcome of the warrant exercise

Oslo, Norway, November 21, 2022 – On November 16, 2022, the exercise period for Genetic Analysis AS's ("GA" or the "Company") warrants of se...

Cision • 21 Nov 2022 08:00

Sista dag för handel med teckningsoptioner av serie TO 1 är den 14 november 2022

Oslo, Norge, 10 november 2022 – Den 14 november 2022 är sista dag för handel med teckningsoptioner av serie TO 1, som emitterades i samband ...

Cision • 10 Nov 2022 12:33

Last day of trading in warrants of series TO 1 is November 14, 2022

Oslo, Norway, November 10, 2022 – November 14, 2022, is the last day of trading in warrants of series TO 1, which were issued in connection ...

Cision • 10 Nov 2022 12:33

RÄTTELSE: Information avseende nyttjandeperiod av teckningsoptioner av serie TO 1 i Genetic Analysis

Det pressmeddelande som publicerades den 2 november 2022, kl 08:00 CET, angav felaktigt den 16 november 2022 som datum för sista dag för han...

Cision • 09 Nov 2022 13:09

CORRECTION: Information regarding the exercise period of warrants of series TO 1 in Genetic Analysis

The press release published on November 2, 2022, at 08:00 CET, incorrectly stated November 16, 2022, as the last day of trading in warrants ...

Cision • 09 Nov 2022 13:09

Genetic Analysis AS ingår avtal med ledande diagnostikbolag om distribution av GA-map[®] i Europa

OSLO, NORGE - 7 november 2022: Genetic Analysis AS ("GA"), specialist på molekylär diagnostik, meddelar idag att GA har ingått ett avtal med...

Cision • 07 Nov 2022 08:00